Literature DB >> 16959390

Determinants for the adoption of angiotensin II receptor blockers by general practitioners.

Jacoba P Greving1, Petra Denig, Willem Jan van der Veen, Frank W Beltman, Miriam C J M Sturkenboom, Flora M Haaijer-Ruskamp.   

Abstract

Results of studies conducted 10-20 years ago show the prominence of commercial information sources in the adoption process of new drugs. Over the past decade, there has been a growing emphasis on practicing evidence-based medicine in drug prescribing. This raises the question whether professional information sources currently counterbalance the influence of commercial information sources in the adoption process. The aim of this study was to identify determinants influencing the adoption of a new drug class, the angiotensin II receptor blockers (ARBs), by general practitioners (GPs) in The Netherlands. A retrospective study was conducted to assess prevalent ARB prescribing for hypertensive patients using the Integrated Primary Care Information (IPCI) database. We conducted a survey among all GPs who participated in the IPCI project in 2003 to assess their exposure to commercial and professional information sources, perceived benefits and risks of ARBs, perceived influences of the professional network, and general characteristics. Multilevel logistic regression was applied to identify determinants of ARB adoption while adjusting for patient characteristics. Data were obtained from 70 GPs and 9470 treated hypertensive patients. A total of 1093 patients received ARBs (12%). GPs who reported frequent use of commercial information sources were more likely to prescribe ARBs routinely in preference to other antihypertensives, whereas GPs who used a prescribing decision support system and those who were involved in pharmacotherapy education were less likely to prescribe ARBs. Other factors that were associated with higher levels of ARB adoption included a more positive perception of ARBs regarding their effectiveness in lowering blood pressure, and working in single-handed practices or in rural areas. Aside from determinants related to the patient population, adoption of a new drug class among Dutch GPs is still determined more by their reliance on promotional information than by their use of professional information sources.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16959390     DOI: 10.1016/j.socscimed.2006.07.019

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  15 in total

Review 1.  Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review.

Authors:  Geoffrey K Spurling; Peter R Mansfield; Brett D Montgomery; Joel Lexchin; Jenny Doust; Noordin Othman; Agnes I Vitry
Journal:  PLoS Med       Date:  2010-10-19       Impact factor: 11.069

2.  Patient educational level and use of newly marketed drugs: a register-based study of over 600,000 older people.

Authors:  Syed Imran Haider; Kristina Johnell; Gunilla Ringbäck Weitoft; Mats Thorslund; Johan Fastbom
Journal:  Eur J Clin Pharmacol       Date:  2008-08-10       Impact factor: 2.953

3.  How quickly do physicians adopt new drugs? The case of second-generation antipsychotics.

Authors:  Haiden A Huskamp; A James O'Malley; Marcela Horvitz-Lennon; Anna Levine Taub; Ernst R Berndt; Julie M Donohue
Journal:  Psychiatr Serv       Date:  2013-04-01       Impact factor: 3.084

4.  Utilisation of angiotensin receptor blockers in Sweden: combining survey and register data to study adherence to prescribing guidelines.

Authors:  Pia Frisk; Tor-Olov Mellgren; Niklas Hedberg; Anita Berlin; Fredrik Granath; Björn Wettermark
Journal:  Eur J Clin Pharmacol       Date:  2008-08-15       Impact factor: 2.953

5.  Income differences in the type of antihypertensive medicines used in ambulatory settings in Finland: a register-based study.

Authors:  Härkönen Mirva; Timonen Johanna; Tervola Jussi; Katri Aaltonen
Journal:  Eur J Clin Pharmacol       Date:  2015-07-31       Impact factor: 2.953

6.  Therapeutic traditions, patient socioeconomic characteristics and physicians' early new drug prescribing--a multilevel analysis of rosuvastatin prescription in south Sweden.

Authors:  Henrik Ohlsson; Basile Chaix; Juan Merlo
Journal:  Eur J Clin Pharmacol       Date:  2008-10-04       Impact factor: 2.953

7.  Who Were the Early Adopters of Dabigatran?: An Application of Group-based Trajectory Models.

Authors:  Wei-Hsuan Lo-Ciganic; Walid F Gellad; Haiden A Huskamp; Niteesh K Choudhry; Chung-Chou H Chang; Ruoxin Zhang; Bobby L Jones; Hasan Guclu; Seth Richards-Shubik; Julie M Donohue
Journal:  Med Care       Date:  2016-07       Impact factor: 2.983

8.  What differentiates primary care physicians who predominantly prescribe diuretics for treating mild to moderate hypertension from those who do not? A comparative qualitative study.

Authors:  Christian M Rochefort; Julia Morlec; Robyn M Tamblyn
Journal:  BMC Fam Pract       Date:  2012-02-29       Impact factor: 2.497

9.  Selection of medicines in Chilean public hospitals: an exploratory study.

Authors:  Juan F Collao; Felicity Smith; Nick Barber
Journal:  BMC Health Serv Res       Date:  2013-01-07       Impact factor: 2.655

10.  Medical school gift restriction policies and physician prescribing of newly marketed psychotropic medications: difference-in-differences analysis.

Authors:  Marissa King; Connor Essick; Peter Bearman; Joseph S Ross
Journal:  BMJ       Date:  2013-01-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.